INDEPENDENT PEPTIDE EDUCATION · UPDATED WEEKLY · NOT FOR SALE TO THE PUBLIC
Home / Peptides / BPC-157
Recovery & healing peptide

BPC-157, explained without the hype

It's the most-searched recovery peptide in the world — and one of the most over-promised. Here's what BPC-157 actually is, what the science does and doesn't show, and exactly where it stands with the FDA in 2026.

Type
Peptide
Pentadecapeptide, 15 amino acids
Derived from
Gastric
A sequence in gastric-juice protein
FDA status
Unlisted
Not approved · under PCAC review
Commonly reported dose
0.25–0.5 mg
Per day · suggestion, not approved or standardized

What is BPC-157?

BPC-157 (sometimes written "BP-157" or "PB-157") is a synthetic pentadecapeptide — a chain of 15 amino acids based on a sequence found in human gastric-juice protein. In the lab and in animal studies it has been investigated mostly for tissue repair: tendons, ligaments, muscle, and the gut lining. It is not a vitamin, a supplement, or an approved medication.

The honest headline: most of the evidence is preclinical — cell and animal models. Rigorous human clinical trials are very limited, so claims that it "heals" specific injuries in people run ahead of the data. That gap between loud marketing and thin human evidence is exactly what this page exists to close.

BPC-157 is not an FDA-approved drug. Its status has moved a lot recently, and the nuance matters:

  • It was placed in the FDA's Category 2 ("do not compound") list in September 2023.
  • It was removed from Category 2 in April 2026 — but it was not added to the 503A bulks list. It is currently unlisted.
  • A Pharmacy Compounding Advisory Committee (PCAC) meeting on July 23–24, 2026 is set to consider adding it to the bulks list.

Want the live picture? Our regulatory-status tracker shows exactly where BPC-157 and other peptides stand right now, with the dated primary sources.

What the research actually shows

In animal models, BPC-157 has been reported to influence pathways involved in healing and blood-vessel formation, with studies looking at tendon-to-bone healing, gut protection, and recovery from certain injuries. Researchers describe a wide safety margin in those animal studies.

In humans, the picture is far thinner: there are few controlled clinical trials, and much of what circulates online is anecdote, not data. That doesn't mean it "doesn't work" — it means the evidence needed to say it does, safely, in people, largely isn't there yet. Treat confident before-and-after claims with skepticism.

Dosage & how it's reconstituted

Because BPC-157 isn't FDA-approved, there is no official dosing. Doses commonly reported by clinics and the wider community sit around 0.25–0.5 mg per day (250–500 mcg), subcutaneously. These are not approved or standardized doses — they reflect what's commonly used today, shared for education, not as a recommendation. Any decision belongs with a licensed provider.

BPC-157 typically ships as a freeze-dried (lyophilized) powder that must be reconstituted with bacteriostatic water before it's a liquid. The math — concentration and the volume to draw — trips a lot of people up, and a misplaced decimal in micrograms is a 1,000× error. That's what our free tool is for:

Reconstitution & draw calculator

Enter the vial and your numbers → exact concentration and units to draw.

Open the calculator →

Side effects & safety

Human safety data is limited. Commonly reported effects are mild and local (for example, irritation at an injection site), but long-term safety in humans is simply not well established, and product quality varies enormously between sources. Because much of the supply is research-use-only and unregulated, purity, sterility, and accurate labeling are real concerns — which is why sourcing and testing matter as much as the molecule itself.

How to do this responsibly

If you're considering BPC-157, the responsible path runs through a licensed provider who can weigh your situation, not a checkout page. Questions worth asking: Is there third-party testing and a certificate of analysis? What's the source and is it disclosed? What does the provider make of the current legal status? This isn't legal or medical advice — it's the baseline diligence any unapproved substance deserves.

Frequently asked questions

Is BPC-157 a steroid?

No. It's a peptide — a short chain of amino acids — not an anabolic steroid or hormone.

Is BPC-157 banned?

It's on the World Anti-Doping Agency (WADA) prohibited list for athletes, and it is not FDA-approved. "Banned" depends on context — competition, prescription, and import rules all differ. Verify for your situation.

BPC-157 vs. TB-500 — what's the difference?

They're different peptides often discussed together for recovery. We cover TB-500 separately in the library; the same caveats about limited human evidence apply.

Where can I buy BPC-157?

We don't sell peptides and we don't direct consumers to buy unapproved substances. If a licensed provider determines it's appropriate, sourcing and testing should be part of that conversation.

Sources

  1. U.S. FDA — Bulk Drug Substances Used in Compounding Under Section 503A of the FD&C Act. fda.gov
  2. FDA Law Blog — "FDA's Pep(tide) Rally: What Compounders and Industry Need to Know" (Apr 2026). thefdalawblog.com
  3. Sikiric P, et al. — Reviews of the stable gastric pentadecapeptide BPC-157 (preclinical literature). (citation to be finalized)
  4. Peptide Pulse — live peptide regulatory-status tracker. View tracker

Educational information only. Not medical, legal, or regulatory advice, not a dosing, treatment, or efficacy claim, and not a recommendation to obtain or use any substance. Many peptides are not FDA-approved; some are labeled research-use-only ("not for human use"). Regulatory status changes frequently — verify independently and consult a licensed provider before any health decision. Published by Health Pro Distributors. © 2026.